Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Atopic Dermatitis Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07185282
What this trial is testing

MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Minghui Pharmaceutical (Hangzhou) Ltd 375
Early research (Phase 1)Study completedNCT05729074
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Who this might be right for
Mild to Moderate Atopic Dermatitis
HK inno.N Corporation 81
Testing effectiveness (Phase 2)Looking for participantsNCT07073677
What this trial is testing

Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

Who this might be right for
Mild to Moderate Atopic Dermatitis
HK inno.N Corporation 162
Not applicableStudy completedNCT07537751
What this trial is testing

Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Noura Abdelmoneim Mohammed Elseessy 40
Testing effectiveness (Phase 2)Study completedNCT02757729
What this trial is testing

Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amorepacific Corporation 192
Not applicableStudy completedNCT06687512
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

Who this might be right for
Atopic Dermatitis
NovoBliss Research Pvt Ltd 44
Post-approval studies (Phase 4)Study completedNCT00130364
What this trial is testing

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis 200
Large-scale testing (Phase 3)Study completedNCT02965118
What this trial is testing

CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amorepacific Corporation 240
Testing effectiveness (Phase 2)Study completedNCT02456480
What this trial is testing

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Maruho Co., Ltd. 37
Testing effectiveness (Phase 2)Study completedNCT04313400
What this trial is testing

Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amytrx Therapeutics, Inc. 91
Not applicableWithdrawnNCT01691209
What this trial is testing

Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bayer
Testing effectiveness (Phase 2)Study completedNCT03091426
What this trial is testing

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Maruho Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01301508
What this trial is testing

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 46
Post-approval studies (Phase 4)Study completedNCT00510003
What this trial is testing

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT03394677
What this trial is testing

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Dermavant Sciences GmbH 110
Very early researchStudy completedNCT04635072
What this trial is testing

Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
RCSI & UCD Malaysia Campus 75
Not applicableStudy completedNCT06553417
What this trial is testing

Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Dr. Soetomo General Hospital 60
Post-approval studies (Phase 4)Study completedNCT00150059
What this trial is testing

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis
Testing effectiveness (Phase 2)Study completedNCT03571620
What this trial is testing

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Qurient Co., Ltd. 258
Not applicableNot Yet RecruitingNCT07519174
What this trial is testing

Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

Who this might be right for
Atopic Dermatitis
Foundation University Islamabad 72
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation